Search Results
Rheumatology: COVID-19 implications for lungs & fibrosis - parallels with diffuse systemic sclerosis
COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Recent Therapeutic Trials for Scleroderma: The Good , The Bad and The Hopeful - Murray Baron, MD
Patient Forum: Fibrotic Lung Disease in Systemic Sclerosis (2022)
Systemic Sclerosis: Grand Rounds in Rheumatology
PFF COVID-19 Guidance
Pulmonary Fibrosis and COVID 19 Webinar with French Captions
Scleroderma and Fibrosis - John Varga
Respiratory Medicine meets Rheumatology: What is new in Connective Tissue Diseases- ILD
IL-6 and its role in scleroderma: Is Tocilizumab a potential treatment modality - RheumaCon 2021
COVID 19 for the Immunocompromised in 2022, Marc Foca, MD, Kids Get Scleroderma, Too!
COVID-19 and the pulmonary circulation
